IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 27 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $27,000 | +440.0% | 17,599 | +467.9% | 0.00% | – |
| Q4 2023 | $5,000 | -16.7% | 3,099 | 0.0% | 0.00% | – |
| Q3 2023 | $6,000 | -33.3% | 3,099 | -1.6% | 0.00% | – |
| Q2 2023 | $9,000 | -88.9% | 3,149 | -89.3% | 0.00% | – |
| Q1 2023 | $81,000 | – | 29,319 | +58538.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 50 | -83.3% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -86.7% | 300 | -89.2% | 0.00% | – |
| Q4 2021 | $15,000 | -31.8% | 2,767 | -23.4% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 3,611 | +9.0% | 0.00% | – |
| Q2 2021 | $20,000 | +566.7% | 3,312 | +1004.0% | 0.00% | – |
| Q1 2021 | $3,000 | -50.0% | 300 | -23.3% | 0.00% | – |
| Q4 2020 | $6,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,058,035 | $2,931 | 0.15% |
| Gradient Capital Advisors, LLC | 26,808 | $74,258 | 0.03% |
| Federation des caisses Desjardins du Quebec | 57,974 | $160,588 | 0.00% |
| WEST PACES ADVISORS INC. | 1,665 | $4,612 | 0.00% |
| Belvedere Trading LLC | 3,400 | $9,418 | 0.00% |
| Belvedere Trading LLC | 2,000 | $5,540 | 0.00% |
| Belvedere Trading LLC | 9,739 | $26,977 | 0.00% |
| CITIGROUP INC | 7 | $19 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $48,430 | 0.00% |
| CIBC WORLD MARKET INC. | 42,427 | $118 | 0.00% |